Aetna And Fresenius Medical Care North America Partner to Treat ESRD Patients
Aetna and FMC-NA are extending their value-based arrangement to better treat patients with ESRD—who are now eligible to enroll in Medicare Advantage (MA) plans. The partners will align reimbursement with quality benchmarks and develop metrics tied to CMS measures to better manage ESRD care.
Read the full article » | Posted 05-14-2021
Related Articles
- Fresenius Medical Care named Shervin Korangy as CEO Posted 10-22-2026
- Aligning Clinical Excellence with Health System Goals Through PD in Value-Based Models Posted 10-22-2026
- Update on National Institutes of Health websites Posted 10-22-2026
- What to Know About the American Society of Nephrology Kidney Week Posted 10-22-2026

